ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,226,512 | +23.1% | 118,884 | +39.4% | 0.01% | 0.0% |
| Q2 2023 | $2,620,769 | -37.4% | 85,256 | -26.6% | 0.01% | -28.6% |
| Q1 2023 | $4,187,731 | -20.5% | 116,229 | -12.8% | 0.01% | -30.0% |
| Q4 2022 | $5,268,846 | +6.0% | 133,321 | +7.8% | 0.01% | 0.0% |
| Q3 2022 | $4,969,000 | +105.9% | 123,673 | +115.5% | 0.01% | +400.0% |
| Q2 2022 | $2,413,000 | +164.9% | 57,382 | +145.2% | 0.00% | +100.0% |
| Q1 2022 | $911,000 | -18.1% | 23,405 | -16.2% | 0.00% | 0.0% |
| Q4 2021 | $1,113,000 | +82.5% | 27,917 | +65.3% | 0.00% | – |
| Q3 2021 | $610,000 | +45.6% | 16,885 | +65.2% | 0.00% | – |
| Q2 2021 | $419,000 | +94.0% | 10,223 | +106.0% | 0.00% | – |
| Q1 2021 | $216,000 | -12.9% | 4,963 | 0.0% | 0.00% | – |
| Q4 2020 | $248,000 | – | 4,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |